Girard Partners’s Idexx Laboratories IDXX Stock Holding History

Girard Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.21M	Hold	2,488	–	–	0.11%	130
2024 Q1	$1.34M	Sell	2,488 -177	-7%	-$96.7K	0.13%	126
2023 Q4	$1.48M	Hold	2,665	–	–	0.15%	123
2023 Q3	$1.17M	Sell	2,665 -179	-6%	-$89.3K	0.13%	128
2023 Q2	$1.43M	Sell	2,844 -3	-0.1%	-$1.44K	0.15%	119
2023 Q1	$1.42M	Hold	2,847	–	–	0.16%	118
2022 Q4	$1.16M	Sell	2,847 -13	-0.5%	-$5.05K	0.13%	141
2022 Q3	$931K	Sell	2,860 -50	-2%	-$18.4K	0.12%	131
2022 Q2	$1.02M	Hold	2,910	–	–	0.13%	124
2022 Q1	$1.59M	Buy	+2,910	New	+$1.53M	0.17%	110
2018 Q4	–	Sell	-50	Closed	-$12K	–	490
2018 Q3	$12K	Buy	+50	New	+$12.1K	﹤0.01%	698

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Girard Partners's IDXX Position: Q2 2024 in Review

Girard Partners held its Idexx Laboratories (IDXX) position steady in Q2 2024 at 2,488 shares worth $1.21M. The position accounts for 0.11% of the portfolio, ranked #130.

Girard Partners first reported a position in IDXX in Q3 2018 and has held it in 11 quarters since. The position peaked at $1.59M in Q1 2022. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Girard Partners held 2,488 shares of Idexx Laboratories worth $1.21M as of Q2 2024.
Girard Partners left its Idexx Laboratories share count unchanged in Q2 2024.
Idexx Laboratories made up 0.11% of Girard Partners's portfolio in Q2 2024, its #130 holding.
Girard Partners first reported a position in Idexx Laboratories in Q3 2018 and has held it in 11 quarters since.
Girard Partners's Idexx Laboratories position peaked at $1.59M in Q1 2022.
1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.